Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
PureBiologix Premium Proprietary Hand Sanitizer Now Available to the Public
PureBioLogix announced today as part of its contribution in the fight of reducing COVID-19 spread, its Premium Hand Sanitizer is now available to the public in bulk at an exceptionally discounted price. PureBioLogix supplies alcohol-free hand sanitizer to first responders as well as police,... - April 29, 2021 - Smartgreen Innovations /Purebiologix
Vesalio Attains Key FDA Clinical Study Milestone
Vesalio announces it has accomplished a key FDA IDE study milestone to support entry into the US neurovascular market. Enrollment in the VITAL(1) clinical trial, assessing the company’s NeVa VS™ technology in the treatment of symptomatic cerebral vasospasm following aneurysmal... - April 28, 2021 - Vesalio
Nascate Launches Pathfinder Application to Improve COVID-19 Vaccine Adherence
Pathfinder insights enable evidence-based geographical targeting of COVID-19 vaccine interventions, enhancing vaccine deployment efficiencies and increasing vaccine uptake. - April 28, 2021 - Nascate
Foster Institute Receives IRB Approval to Proceed with Development of a National Registry on the Safety and Utilization of Hemp Cannabinoids
Foster Institute LLC, a Kentucky based think tank and research institute, announced today it has received Institutional Review Board (“IRB”) protocol approval for the development of the first mobile technology led national registry on the safety and utilization of Hemp... - April 28, 2021 - Foster Institute
Innovation and Value Initiative to Hold Second Methods Summit to Drive Patient-Centered Value Assessment
Summit will Address Priority Patient Inputs for Comparative Effectiveness Research and HTA. - April 27, 2021 - Innovation and Value Initiative
Linshom Receives SBIR Phase II Contract Award from the United States Air Force for Its Dual Purpose Respiratory Device
Linshom announced today receipt of a phase II SBIR contract award with the United States Air Force (USAF) to fund ongoing development and deployment of the Linshom Predictive Continuous Respiratory Monitoring (LPCRM) System. The $748K contract follows successful completion of a SBIR phase 1 award... - April 27, 2021 - Linshom
CTO, Rich Goldstein, Named 2021 Digi-Tech Innovator Honoree
Cancer Expert Now's Chief Technology Officer, Dr. Rich Goldstein, recognized as a 2021 Digi-Tech Innovator Honoree. - April 23, 2021 - Cancer Expert Now, Inc.
Immundiagnostik, Inc. Transitions to Eco-Friendly Kit Packaging to Further Support Sustainable Laboratory Initiatives
North American immunoassay supplier Immundiagnostik, Inc. has transitioned its ELISA and assay kit packaging to eco-friendly materials to further support sustainable laboratory initiatives. The new bio-based packaging made by Paper Foam® is 100% compostable and eco-friendly. In addition, the organization offers custom bulk packaging services for high throughput labs working to reduce their environmental impact. More information can be found at https://www.idkna.com. - April 21, 2021 - Immundiagnostik, Inc.
Mitolytix Novel Biomolecule Converts Malignant Phenotype to Benign Status
A new biomolecule developed my Mitolytix Research, referred to as a "Catalyst," significantly induce necrosis of malignant tumors without histological changes in adjacent nontumorous tissue. The objective is tumor “normalization,” in contrast to “expeditious tumor destruction.” While some similarities between the tumor response of chemo-radiotherapy and the catalyst are observed, several differences are noted. - April 17, 2021 - Mitolytix
Court Square Group and 5thPort Announce Life Science Industry Partnership
Court Square Group and 5thPort’s Partnership helps life science companies streamline clinical trials and procedures, increase regulatory compliance, and shorten time to market. - April 15, 2021 - Court Square Group
Ambit, Inc. Announces the Release of AmbitVPN’s Post-Quantum Native Windows Application
Ambit, Inc., a US based post-quantum cybersecurity company, announces the release of AmbitVPN’s Post-Quantum Windows desktop - www.ambitvpn.com. This new native VPN Windows application is 4x faster than the initial beta while achieving near-line speed on internal tests. This positions the company’s Post-Quantum VPN as a market leader in speed and security for their users on Android and iOS mobile apps, as well as Mac desktop. Linux desktop users will have AmbitVPN soon too. - April 08, 2021 - Ambit Inc.
GeneThera, Inc. Wastewater Testing: a Way to Better Control the COVID-19 Pandemic
The global COVID-19 pandemic has demonstrated that neither current systems nor related technologies are capable of preventing or even successfully controlling the spread of zoonotic infectious agents. One of the prominent features of these infectious organisms is their ability to infect both people... - March 30, 2021 - GeneThera Inc.
Metro Safety Training Offers Red Cross Certified Emergency First Aid Training with CPR/AED Level C Valid for 3 Years
The renowned training school offers first aid training and workplace safety courses with accredited certifications in British Columbia. - March 27, 2021 - Metro Safety Training
Best Health Care Website to be Named by Web Marketing Association in 25th Annual WebAward Competition
The Web Marketing Association will name the best healthcare websites of 2021 as part of their 25th annual international WebAward Competition for Web site development at www.webaward.org. The WebAwards sets benchmarks for 96 industries, including healthcare, healthcare provider, medical, medical equipment, biotechnology and pharmaceutical websites. - March 16, 2021 - Web Marketing Association
Eurofins Viracor BioPharma Launches PanCancerIQ Comprehensive Genomic Profiling Service to Advance Precision Oncology Clinical Drug Development
Eurofins Viracor BioPharma Services, a global leader in specialty bioanalytical testing services, announces the launch of their new PanCancerIQ genomic profiling test; a next-generation sequencing (NGS) service that enables comprehensive genomic profiling of tumor samples. In addition to expanding... - March 11, 2021 - Eurofins Viracor BioPharma
OrthoNeuro Orthopedic Surgeon Dr. Mark Gittins Engages in Partnership to Provide Remote Physician Surgical Training
OrthoNeuro orthopedic surgeon Mark Gittins, DO, FAOAO, has engaged in a cutting-edge partnership to provide remote physician surgical training. He has partnered with Avail Medsystems, a medical technology company pioneering telemedicine for the operating room (“Procedural... - March 09, 2021 - OrthoNeuro
New York Cancer & Blood Specialists Announces Ruth M. Morgan, DC as Chief Research Officer
New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, announces Ruth M. Morgan, DC, as Chief Research Officer. In this position, Ruth will oversee all research operations, providing leadership to ensure excellence in research performance and... - March 09, 2021 - New York Cancer & Blood Specialists
Gwinnett County's CardioVascular Group Adds New Physician
CardioVascular Group, a cardiology practice which has serviced the north Atlanta metropolitan area for more than 30 years, has hired Dr. Lin Gao. Her first day was Feb. 1. - March 01, 2021 - CardioVascular Group Atlanta
Tigerlily Foundation Joins AACR and 130 Other Organizations in Heartfelt Letter to President Biden
Tigerlily Foundation, a national breast cancer organization, is banding together with the American Association for Cancer Research (AACR) and 130 organizations, cancer centers and other institutions in soliciting the support of President Biden regarding the COVID-19 pandemic vaccination schedule... - February 20, 2021 - Tigerlily Foundation
Stargardt Disease - MD Stem Cells New Treatment Improves Vision
Stem Cell Ophthalmology Treatment Study (SCOTS) show positive results in 84% of eyes. - February 18, 2021 - MD Stem Cells
Paras Biopharmaceuticals Finland Oy Affordable Healthcare Efforts Viewed in Over 90 Countries: Biosimilar Technologies Get Attention
Paras Biopharmaceuticals Finland Oy (Paras Biopharma) is a Finland-based microbial biologics company which focuses on the development of technologies for biosimilars and biologics in an efficient manner. The overall objective of Paras Biopharma is to enable economical production and future availability of affordable medicines for unmet medical needs. - February 17, 2021 - Paras Biopharmaceuticals Finland Oy
Riem Badr, MD, FCAP Named Chief of Pathology and Laboratory Services
New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, has named board-certified hematopathologist Riem Badr, MD, FCAP, the chief of Pathology and Laboratory Services. https://nycancer.com/blog/2021/02/16/riem-badr-md-fcap-named-chief-pathology/ Dr. - February 16, 2021 - New York Cancer & Blood Specialists
Phase One Development of Rapid COVID-19 Point of Care Test Complete
Pepex Biomedical has effectively concluded first stage development efforts including successfully demonstrating working chemistry and manufacturing functionality of its existing electrochemical biosensor. - February 11, 2021 - Pepex Biomedical, Inc.
MedAware Systems Launches AI Post Market Surveillance for Neuromodulation Devices
MedAware Systems’ Science of Health Informatics (SOHInfo) announces the launch of its comprehensive AI-powered surveillance service for Spinal Cord and Peripheral Nerve stimulation devices from all major manufacturers. The Neuromodulation Device surveillance service satisfies both FDA and... - February 11, 2021 - Biomed Industries Inc.
OrthoNeuro to Open New Office on Dublin Campus Of Ohio University Heritage College of Osteopathic Medicine
OrthoNeuro President, Larry T. Todd, Jr. DO, announced today that the practice will open a new office on the Dublin Campus of Ohio University Heritage College of Osteopathic Medicine (OUHCOM). The office is slated to open in early spring and will house a physician office and physical therapy clinic. - February 03, 2021 - OrthoNeuro
New York Cancer & Blood Specialists Announces Richard Zuniga, MD as Chief of Research
New York Cancer & Blood Specialists (NYCBS), one of the nation’s leading oncology practices, announces Richard Zuniga, MD, as the Chief of Research. https://nycancer.com/blog/2021/02/02/chief-of-research/ Dr. Zuniga is a board-certified hematologist and oncologist at NYCBS. Before... - February 03, 2021 - New York Cancer & Blood Specialists
Family Medicine Physician, Bianca Garcia, MD Joins New York Health
New York Health (NY Health) is proud to announce that board-certified Family Medicine physician, Bianca Garcia, MD has joined the multidisciplinary team of physicians. She will be practicing at 69 W Main St., Bay Shore, NY... - February 03, 2021 - New York Health
MedAware Systems Launches Event Surveillance for Drug Eluting Stents
MedAware Systems’ Science of Health Informatics (SOHInfo) is offering a comprehensive surveillance service for drug eluting stents. The service reports events from leading regulatory databases along with published articles in the medical literature. SOHInfo Surveillance continuously extracts... - January 28, 2021 - Biomed Industries Inc.
AltuCell Therapeutics Announces Proof-of-Concept in Lead Programs in Type 1 Diabetes in Human Subjects; Phase 1 Pilot in Humans Has IND Approval & Trial to Begin Shortly
AltuCell Therapeutics, Inc., AltuCell announced today the achievement of approval of IND in Italy after pre-clinical proof-of-concept based on data from its two lead programs for type 1 diabetes testing of cadaver stem cell-derived islets in both human and non-human subjects. Their capsules have been implanted in people with diabetes for 5 year, demonstrating long-term safety, with no toxicity or tissue necrosis, and no rejection in any of the patients treated. - January 15, 2021 - AltuCell Therapeutics
New York Cancer & Blood Specialists Appoints Chief Radiation Oncologist
New York Cancer & Blood Specialists (NYCBS), announced Talha Shaikh, MD, MBA, has been named chief radiation oncologist. - January 14, 2021 - New York Cancer & Blood Specialists
Coronavirus Was Found to be Inactive on Roppe® Non-Porous Rubber Flooring After 24 Hours
Independent testing disputes the widely accepted view that the coronavirus can live on surfaces for up to seven days. - January 12, 2021 - Roppe Holding Company
Ultra-Low Temperature Freezers for Vaccine and Laboratory Cold Storage Introduced by ATS
ATS announces both freestanding and portable freezers for vaccines, biological materials, and biomedical uses. The ultra-low temperature freezers can continuously store biological materials, including vaccines, at temperatures as low as -86°C (-123°F) with +/- 0.1°C accuracy. - January 07, 2021 - Advanced Thermal Solutions, Inc.
Immundiagnostik, Inc. Launches New Website to Support Research and Clinical Laboratories
Immundiagnostik, Inc., a North American immunoassay provider, has launched its new website to support research and clinical laboratories working toward improving patient care. The site offers a more convenient way for labs of all sizes to purchase immunoassays and other diagnostic detection tools, as well as learn about lab support and customized bulk packaging services. More information can be found at https://idkna.com - January 05, 2021 - Immundiagnostik, Inc.
Studies Reveal CBD May Protect Against COVID-19; OC Wellness Solutions' CBD Tinctures and Oils Available
Clinical trials have shown CBD could be effective in reducing the cytokine storm in COVID-19 patients. - January 04, 2021 - OC Wellness Solutions
Moms Take on the World for Sick Kids
Inspired by their children's fight for survival, moms take on the world for treatment of devastating birth defect to save other peoples' children. - December 31, 2020 - CDH International
Power Wellness Safely Surpasses 1 Million Medical Fitness Center Visits
Collectively across 29 locations nationwide, Power Wellness has managed over 1 million visits since reopening their first client’s location in May 2020. As a result of strictly enforced safety protocols, the reported COVID-19 positive reports from staff and members have been below 0.05%, and... - December 23, 2020 - Power Wellness Management
Tigerlily Foundation to Lead Historic Special Session on Health Equity, Collaboration and Partnership at the 2020 San Antonio Breast Cancer Virtual Symposium
Tigerlily Foundation, a national breast cancer organization established by a Black, first-generation immigrant woman and patient-led organization will open the San Antonio Breast Cancer Symposium (SABCS). Maimah Karmo, President and Founder of the Tigerlily Foundation, has set the stage for a new... - December 07, 2020 - Tigerlily Foundation
Tigerlily Foundation to Lead Historic Special Session on Health Equity, Collaboration and Partnership at the 2020 San Antonio Breast Cancer Virtual Symposium
Tigerlily Foundation co-hosts this historic special session in collaboration with the American Association for Cancer Research (AACR), titled Setting the Stage for Health Equity, Collaboration and Partnership, on December 8, 2020, to discuss continued collaborative action towards health equity in breast cancer care, at SABCS 2020. The event is designed to foster transformational dialogue and lead to specific strategies to end barriers at every level of healthcare for people of color. - December 05, 2020 - Tigerlily Foundation
Intelliversity Announces Project Jericho
An example of “health-care diplomacy” at work - November 23, 2020 - Intelliversity
Bixahuman Invests Heavily in Research and Development for Their Natural Products
Health and wellness company Bixahuman has spent over 8 years researching and developing their range of supplements and products. - November 12, 2020 - BixaHuman
Erica Cai Named ALPCO’s Summer 2020 Diabetes Research Travel Grant Recipient
Today ALPCO announced Erica Cai from Harvard Medical School as the latest recipient of its Diabetes Research Travel Grant. Dr. Cai is a postdoctoral fellow from the Joslin Diabetes Center researching the mechanism of autoimmunity that leads to beta cell destruction and type 1 diabetes (T1D). Dr. - November 10, 2020 - ALPCO
New Rapid COVID-19 Point of Care Test
Pepex Biomedical has diverted funds and resources to the development of Multiple Rapid COVID-19 Tests designed to accurately identify Antigens (diagnostic to detect active virus) and Antibodies (to determine immunity) in under 15 minutes with 95% accuracy. - November 09, 2020 - Pepex Biomedical, Inc.
Artificial Intelligence Search Technology Will be Used to Help Modernize US Federal Pathology Facility
Technology developed by Canadian researchers has been adopted by the Joint Pathology Center (JPC), which has the world’s largest collection of preserved human tissue samples. The v=center will use an artificial intelligence (AI) search engine to index and search its digital archive as part of a modernization effort. The image search engine was designed by researchers at the Laboratory for Knowledge Inference in Medical Image Analysis (Kimia Lab) at the University of Waterloo. - October 28, 2020 - Kimia Lab, University of Waterloo
CQRC Celebrates National Respiratory Care Week
CQRC urges Congress to pass H.R. 8158 to waive budget neutrality for home oxygen services, supplies and equipment. - October 26, 2020 - CQRC
Innovation and Value Initiative Selects Pharmerit to Construct Foundation of Major Depressive Disorder Value Assessment Model
Health Economics Experts to Work with IVI-convened Advisory Group to Assess and Determine Model Inputs - October 20, 2020 - Innovation and Value Initiative
The Palm Beach Hedge Fund Association Announces a Strategic Partnership with Jupiter Orphan Therapeutic
Jupiter Orphan Therapeutics forms strategic partnership with The Palm Beach Hedge Fund Association. - October 15, 2020 - Palm Beach Hedge Fund Association
Veralize Device Team Named Semi-Finalist for XPRIZE Rapid COVID-19 Testing
Team made up of 12-15 Molecular Diagnostics, African Biosciences Ltd. and Ahmadu Bello University has been selected as semi-finalist in the XPRIZE Rapid COVID-19 Testing competition. The patented rapid response diagnostic device designed by 12-15 Molecular Diagnostics can detect COVID-19 using saliva samples. By algorithmically analyzing the results with the 12-15 Molecular Diagnostics machine learning system, the test can provide 95% accuracy and early detection, even when there are no symptom - October 13, 2020 - African Biosciences Inc.
Tigerlily Foundation Launches the "My Life is My Legacy" Hero Campaign
Tigerlily Foundation launches the “My Life is My Legacy” Hero campaign to highlight the various ways individuals are impacted by metastatic breast cancer (mBC) and to increase education and awareness in young women. - October 13, 2020 - Tigerlily Foundation
Evon Medics, LLC Has Been Awarded $1.7 Million Grant for the Evaluation of Its Medical Device for the Treatment of Opioid Use Disorder
Small business, Evon Medics, LLC today announced that it has been awarded a non-dilutive grant of $1.7 million for its Phase II SBIR (Small Business Innovation Research) clinical trials for the development and evaluation of its non-invasive Chemosensory-Based Orbitofrontal Cortex Training (CBOT)... - October 11, 2020 - Evon Medics, LLC
Cayman Receives SBIR Grant for Alzheimer’s Research
The National Institute on Aging (NIA) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies. - October 10, 2020 - Cayman Chemical Company